-
Original Article
-
Korean J Med. 2009;77(2):152-156.
- 내성 결핵균의 실태 및 치료
-
임 재 준
-
- Current status of drug-resistant tuberculosis and its treatment
-
Jae-Joon Yim
-
-
- Abstract
- Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR)-TB and extensively drug resistant (XDR)-TB, poses a
serious threat to global health because it requires treatment for a long duration and frequent hospitalization, and results in a considerable
number of mortalities. In South Korea, MDR is observed in 2.7% of newly diagnosed TB cases and in 14% of re-treatment
cases. In addition, 5~20% of MDR-TB could be categorized as XDR-TB. Treatment regimen for MDR or XDR-TB should include
4~5 drugs susceptible to isolated tuberculous bacilli and should be maintained at least 18 months after culture conversion. Pertinent
combination of anti-TB drugs and solid compliance are the basis of successful treatment for MDR and XDR-TB patients. (Korean
J Med 77:152-156, 2009)
Keywords :Tuberculosis, Drug resistance, Treatment
